Induction of senescence-like state and suppression of telomerase activity through inhibition of HPV E6/E7 gene expression in cells immortalized by HPV16 DNA

Experimental Cell Research

Volumn 277, Issue 2, 2002, Pages 173-182

  Lee, Chan Jae ^a   Suh, Eun Jung ^a   Kang, Hyun Tae ^a   Im, Jun Sub ^a   Um, Soo Jong ^b   Park, Jong Sup ^c   Hwang, Eun Seong ^a  

^a University of Seoul   (South Korea)

^b Sejong University   (South Korea)

^c The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

BPV E2; Cellular senescence; Cervical carcinoma; E6; E7; HPV; Human papillomavirus; Telomerase

Indexed keywords

BETA GALACTOSIDASE; MESSENGER RNA; ONCOPROTEIN; ONCOPROTEIN E2; PROTEIN E6; PROTEIN E7; PROTEIN P53; TELOMERASE; UNCLASSIFIED DRUG; VIRUS DNA;

ADENOVIRUS; ARTICLE; CANCER CELL CULTURE; CELL AGING; CELL COUNT; CELL GROWTH; CELL IMMORTALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MITOSIS INHIBITION; PAPILLOMA VIRUS; PHENOTYPE; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; VIRUS RECOMBINANT; WART VIRUS;

ADENOVIRIDAE; BOVINAE; BOVINE PAPILLOMAVIRUS; BOVINE PARVOVIRUS; HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRUS;

EID: 0036315385     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2002.5554     Document Type: Article

References (65)

1. The serial cultivation of human diploid cell strains
2. A biomarker that identifies senescent human cells in culture and in aging skin in vivo
3. From cells to organisms: Can we learn about aging from cells in culture?
4. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer
5. The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumors
6. Papillomavirus genomes in human cervical tumors: Analysis of their transcriptional activity
7. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines
8. Continuous cell lines with altered growth and differentiation properties originate after transfection of human papillomavirus type 16 DNA
9. Characterization of normal human exocervical epithelial cells immortalized in vitro by papillomavirus types 16 and 18 DNA
10. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes
11. Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human paillomavirus type 18
12. Elevated wild-type p53 protein levels in human epithelial cell lines immortalized by the human papillomavirus type16 E7
13. Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis
14. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
15. E7 protein of human papillomavirus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway
16. Telomerase activation by the E6 gene product of human papillomavirus type 16
17. Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein
18. Telomerase activation by human papillomavirus type 16E6 protein: Induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites
19. E box-dependent activation of telomerase by human papillomavirus type 16 E6 does not require induction of c-myc
20. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells
21. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins
22. Long-term genome stability and minimal genotypic alterations in HPV 16 E7-, but not E6-immortalized human uroepithelial cells
23. p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells
24. Human papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype
25. The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle
26. Bovine papillomavirus E2 transactivating gene product binds to specific sites in papillomavirus DNA
27. The papillomavirus E2 regulatory proteins
28. Trans-activation of an upstream early gene promoter of bovine papillomavirus-1 by a product of the viral E2 gene
29. The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region
30. Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters
31. Functional analysis of E2 mediated repression of the HPV-18 P105 promoter
32. Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition
33. Integration of human papillomavirus type 16 DNA sequences: A possible early event in the progression of genital tumors
34. Physical status and expression of HPV genes in cervical cancers
35. Human papillomavirus and cervical cancer
36. Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene
37. Suppression of cellular proliferation by the papillomavirus E2 protein
38. Activation of the endogenous p53 growth inhibitiory pathway in heal cervical carcinoma cells by expression of the bovine papillomavirus E2 gene
39. Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis
40. Disruption of the human papillomavirus type 16 E2 gene protects cervical carcinoma cells from E2F-induced apoptosis
41. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways
42. Rapid induction of senescence in human cervical carcinoma cells
43. Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21 (CIP)-dependent pathways
44. Replicative senescence and senescence-like state induced in cancer-derived cells
45. A simple technique for the rescue of early region 1 mutation into infectious human adenovirus type 5
46. The effects of the adenovirus-mediated wild-type p53 delivery in human epithelial ovarian cancer cell line in vitro and in vivo
47. Specific association of human telomerase activity with immortal cells and cancer
48. Bovine papillomavirus E2 protein activates a complex growth-inhibitory program in p53-negative HT-3 cervical carcinoma cells that includes repression of cyclin A and cdc25A phosphatase genes and accumulation of hypophosphorylated retinoblastoma protein
49. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells
50. Human papillomavirus type 16 E7 binds to E2F1 and activates E2F1-driven transcription in a retinoblastoma protein-independent manner
51. High sensitivity detection of HPV-16 in SiHa and CaSki cells utilizing FISH enhanced by TSA
52. The introduction of dominant-negative p53 mutants suppresses temperature shift-induced senescence in immortal human fibroblasts expressing a thermolabile SV40 large T antigen
53. Cytogenetic analysis of eight human papillomavirus immortalized human keratinocyte cell lines
54. Integration of human papillomavirus 16 DNA and genomic rearrangements in immortalized human keratinocyte lines
55. Chromosomal characterizations of human nasal and nasopharyngeal cells immortalized by human papillomavirus type 16 DNA
56. Myc activates telomerase
57. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells
58. Intact functional domains of the retinoblastoma gene product (pRb) are required for downregulation of telomerase activity
59. Overexpression of the p21 sdil gene induces senescence-like state in human cancer. cells: Implication for senescence-directed molecular therapy for cancer
60. Telomerase suppression by chromosome 6 in a human papillomavirus type 16-immortalized keratinocyte cell line and in a cervical cancer cell line
61. Inhibition of human telomerase by a retrovirus expressing telomeric antisense RNA
62. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics
63. A highly selective telomerase inhibitor limiting human cancer cell proliferation
64. The Pin2/TRF1-interacting protein PinX1 is a potent telomerase inhibitor
65. Induced senescence in HeLa cervical carcinoma cells containing elevated telomerase activity and extended telomeres